Bm Calcium Sulfide Hepar Sulf (calc Sulf)

Dosage for Calcium Sulfide is highly individualized based on the indication:

• Immunotherapy: Usually starts with a very low dose (e.g., 0.01 mcg to 0.1 mcg) and is gradually increased over several weeks (build-up phase) to a maintenance dose of 100 mcg.
• Metabolic Acidification: Typical doses range from 500 mg to 2 g daily, divided into multiple doses.

Pediatric use is strictly regulated. For insect venom desensitization, children may follow a modified build-up schedule similar to adults, but only under the direct supervision of a pediatric allergist. It is generally not recommended for children under the age of 5 unless the risk of insect stings is life-threatening.

Renal Impairment

Use with caution. Reduced excretion rates may lead to an accumulation of calcium or sulfate ions. Dose reductions of 25-50% may be necessary for patients with a GFR below 30 mL/min.

Hepatic Impairment

No specific adjustments are typically required as the drug is not primarily metabolized by the liver, though overall metabolic status should be monitored.

Elderly Patients

Lower starting doses are recommended due to the increased prevalence of cardiovascular disease and decreased renal function in the geriatric population.

• Injections: Must be administered by a healthcare professional in a clinical setting equipped to handle anaphylaxis.
• Oral Forms: Should be taken with a full glass of water. Your doctor may recommend taking it with food to minimize gastrointestinal upset.
• Storage: Store at controlled room temperature or refrigerate as specified by the manufacturer. Protect from light and moisture.

If you miss a dose of the oral medication, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. For missed immunotherapy injections, contact your allergist immediately, as your build-up schedule may need to be adjusted to ensure safety.

Signs of overdose include severe nausea, vomiting, muscle weakness, and cardiac arrhythmias (irregular heartbeat). In the event of an overdose, seek emergency medical attention or contact a Poison Control Center immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

• Injection Site Reactions: Redness, swelling, and itching at the site of administration. These usually subside within 24 to 48 hours.
• Gastrointestinal Distress: Mild nausea or stomach cramping, particularly with oral forms.

• Urticaria (Hives): Itchy red welts appearing on various parts of the body.
• Headache: Persistent dull pain or pressure.
• Fatigue: A general sense of tiredness following treatment.

• Proteinuria: Presence of excess proteins in the urine, indicating potential kidney stress.
• Hypotension: A sudden drop in blood pressure, leading to dizziness.

> Warning: Stop taking Calcium Sulfide and call your doctor immediately if you experience any of these:

• Anaphylaxis: Difficulty breathing, swelling of the face or throat, rapid pulse, and a feeling of impending doom.
• Angioedema: Deep swelling under the skin, particularly around the eyes or lips.
• Cardiac Arrhythmia: Feeling like your heart is skipping beats or racing uncontrollably.
• Severe Nephrotoxicity: Significant change in urine output or dark-colored urine.

Prolonged use of Calcium Sulfide, particularly for metabolic purposes, may lead to electrolyte imbalances or the formation of different types of kidney stones. Regular monitoring of serum calcium and sulfur levels is required for long-term therapy.

WARNING: RISK OF SEVERE ALLERGIC REACTIONS

Calcium Sulfide, when used as an allergenic extract, can cause life-threatening systemic reactions, including anaphylaxis. Patients must be monitored for at least 30 minutes following administration in a facility equipped with emergency equipment and personnel trained in the management of anaphylaxis. This drug should be prescribed only by physicians experienced in the treatment of allergic diseases.

Report any unusual symptoms to your healthcare provider.

Calcium Sulfide is a potent agent that requires careful clinical management. Patients must be screened for underlying cardiovascular disease before starting therapy, as systemic reactions can place significant stress on the heart.

Calcium Sulfide carries a Black Box Warning regarding the risk of severe, systemic allergic reactions (anaphylaxis). According to the FDA, these reactions can occur even in patients who have previously tolerated the drug without incident. Immediate access to epinephrine is mandatory during administration.

• Anaphylaxis Risk: There is a constant risk of severe allergic reaction during the build-up phase of immunotherapy.
• Cardiotoxicity: Because it acts as an adrenergic agonist, it may exacerbate pre-existing arrhythmias or hypertension.
• Nephrotoxicity: Patients with pre-existing kidney disease must be monitored closely for signs of worsening renal function due to the calcium and sulfur load.
• Asthma Exacerbation: Patients with unstable asthma are at a higher risk for severe reactions and should be stabilized before starting Calcium Sulfide.

Healthcare providers will typically require:

• Baseline and Periodic Lung Function Tests: Especially for patients with asthma.
• Serum Electrolytes: To monitor calcium, potassium, and chloride levels.
• Renal Function Tests: Serum creatinine and GFR monitoring.

Calcium Sulfide may cause dizziness or fatigue shortly after administration. Patients should avoid driving or operating heavy machinery for at least several hours following an injection until they know how the medication affects them.

Alcohol should be avoided on the day of treatment, as it can dilate blood vessels and potentially increase the speed of absorption of the allergen, increasing the risk of a systemic reaction.

Do not stop treatment abruptly without consulting your doctor. In immunotherapy, stopping the maintenance phase can lead to a loss of protection against insect stings, requiring a restart of the build-up phase.

> Important: Discuss all your medical conditions with your healthcare provider before starting Calcium Sulfide.

• Beta-Blockers (e.g., Propranolol, Atenolol): These medications can block the effects of epinephrine, making it difficult to treat a systemic allergic reaction if one occurs during therapy.
• MAO Inhibitors: Combining Calcium Sulfide (which has adrenergic activity) with MAOIs can lead to a hypertensive crisis (dangerously high blood pressure).

• ACE Inhibitors: May increase the risk of severe systemic reactions or angioedema in patients receiving allergenic extracts.
• Tricyclic Antidepressants: Can potentiate the adrenergic effects of Calcium Sulfide, increasing the risk of cardiac arrhythmias.

• Diuretics (Thiazides): May increase the risk of hypercalcemia (excessive calcium in the blood) when taken with Calcium Sulfide.
• Digoxin: High calcium levels can increase the toxicity of digoxin, leading to heart rhythm problems.

• High-Calcium Dairy: Excessive intake of milk or cheese may interfere with the dosing of Calcium Sulfide when used for metabolic purposes.
• Caffeine: May exacerbate the adrenergic side effects, such as jitteriness or increased heart rate.

• St. John’s Wort: May alter the metabolic clearance of components of the extract.
• Calcium Supplements: Concurrent use increases the risk of hypercalcemia and kidney stones.

Calcium Sulfide may interfere with urinary pH tests, serum calcium measurements, and certain coagulation assays. Always inform laboratory personnel if you are taking this medication.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Severe Unstable Asthma: Patients with a FEV1 consistently below 70% of predicted values are at an unacceptable risk for fatal bronchospasm.
• Recent Myocardial Infarction: Patients who have had a heart attack within the last 3-6 months should not use this drug due to its adrenergic activity.
• Hypersensitivity to Components: Any known previous anaphylactic reaction to the non-active ingredients in the formulation.

• Autoimmune Disorders: The use of immunotherapy in patients with active autoimmune disease (e.g., Lupus, Rheumatoid Arthritis) requires a careful risk-benefit analysis, as it may flare the condition.
• Pregnancy: While not strictly contraindicated, starting a new build-up phase during pregnancy is generally avoided.

Patients allergic to other sulfide-containing compounds or specific insect proteins may show cross-reactivity. A thorough allergy history is required before the first dose.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Calcium Sulfide.

Calcium Sulfide is categorized as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Generally, maintenance doses of immunotherapy may be continued, but dose increases are discouraged during pregnancy.

It is not known whether the components of Calcium Sulfide are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman. Most clinicians consider it safe, but monitoring the infant for signs of irritability is advised.

Safety and effectiveness in children under the age of 5 have not been established. For older children, the drug is effective for venom immunotherapy but requires close monitoring of growth and development if used long-term for metabolic conditions.

Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.

Calcium Sulfide is primarily excreted by the kidneys. In patients with renal impairment, the half-life may be significantly prolonged. Dose adjustments based on Creatinine Clearance (CrCl) are mandatory to prevent systemic toxicity.

While not heavily metabolized by the liver, severe hepatic impairment can alter the body's acid-base buffering capacity, making the use of Calcium Sulfide for acidification purposes more unpredictable.

> Important: Special populations require individualized medical assessment.

Calcium Sulfide acts as a Standardized Insect Venom Allergenic Extract by introducing controlled amounts of venom proteins to the immune system. This process shifts the immune response from a Th2-biased (allergic) response to a Th1-biased response, increasing the production of IL-10 and IgG4. Simultaneously, its Adrenergic alpha and beta agonist properties allow it to bind to G-protein coupled receptors, influencing smooth muscle tone. As an Acidifying Activity agent, it provides sulfate ions that can displace bicarbonate, lowering the pH of physiological fluids.

The onset of the acidifying effect is rapid (within 1-2 hours), while the immunotherapeutic effect takes months to develop. Tolerance to the adrenergic effects may develop with repeated dosing, but the immunological tolerance is designed to be long-lasting, often persisting for years after the cessation of a 3-5 year treatment course.

| Parameter | Value |

|---|---|

| Bioavailability | 30-50% (Oral); 100% (SC) |

| Protein Binding | 45% (primarily Albumin) |

| Half-life | 2.5 - 4.0 hours |

| Tmax | 1.5 hours (Oral) |

| Metabolism | Non-enzymatic dissociation; Sulfide oxidation |

| Excretion | Renal 85%, Fecal 15% |

• Molecular Formula: CaS
• Molecular Weight: 72.14 g/mol
• Solubility: Slightly soluble in water; decomposes in moist air.
• Structure: A simple inorganic salt consisting of a calcium cation and a sulfide anion.

Calcium Sulfide is categorized as a Standardized Allergenic Extract and a Calculi Dissolution Agent. It is related to other immunotherapy agents like Honey Bee Venom and Yellow Jacket Venom extracts.